The Family Firm’s Chemours CC Stock Holding History

The Family Firm’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54	Closed	-$1.21K	–	301
2024 Q2	$1.21K	Buy	+54	New	+$1.41K	﹤0.01%	825

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

The Family Firm's CC Position: Q3 2024 in Review

The Family Firm sold out of Chemours (CC) in Q3 2024, closing a stake of 54 shares — an estimated $1.21K sold.

The Family Firm first reported a position in CC in Q2 2024 and held it in 1 quarter. The position peaked at $1.21K in Q2 2024. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

The Family Firm reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 54 Chemours shares in Q3 2024, an estimated $1.21K.
The Family Firm first reported a position in Chemours in Q2 2024 and held it in 1 quarter.
The Family Firm's Chemours position peaked at $1.21K in Q2 2024.
421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.